Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 8Prostatic Neoplasms 7Carcinoma, Non-Small-Cell Lung 3Urogenital Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Prostate Adenocarcinoma 1Neoplasms, Radiation-Induced 1Melanoma 1Lymphatic Metastasis 1Lung Neoplasms 1Locally Advanced Lung Carcinoma 1Glioma 1Genital Neoplasms, Male 1Financial Stress 1Diffuse Intrinsic Pontine Glioma 1Deception 1Carcinoma, Merkel Cell 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Anatomic Stage I Breast Cancer AJCC v8 1Advanced Cancer 1

Interventions

Radiotherapy 5Temozolomide 4Radiation 3Irinotecan 3Bevacizumab 3ribociclib 2abemaciclib 2Vorinostat 2Mebendazole 2Everolimus 2Dasatinib 2vandetanib 1temsirolimus 1sargramostim 1reolysin 1pembrolizumab 1ovex 1nimotuzumab 1irinotecan sucrosofate 1dinutuximab 1crenolanib 1adavosertib 1Vincristine 1Valproic Acid 1Sirolimus 1Re-Irradiation 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation Dose Hypofractionation 1Piperazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Diffuse Intrinsic Pontine Glioma × Radiation Dose Hypofractionation × Clear all
NCT03841435 2023-09-13

Hypofractionated Radiotherapy for Recurrent DIPG

University of Cincinnati

Phase NA Completed
5 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡